C₁₅H₁₂N₂O (P274)
Quantities
| P2067 | mass | 236.094963 |
| P2101 | melting point | 191.5 |
| P3780 | active ingredient in | ... | Q1317532 (Tegretol) | Tegretol |
| P3780 | active ingredient in | ... | Q47521316 (Carbatrol) | Carbatrol |
| P3780 | active ingredient in | ... | Q47521322 (Carnexiv) | Carnexiv |
| P3780 | active ingredient in | ... | Q48828809 (Equetro) | Equetro |
| P233 | canonical SMILES | String | C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N | ??? |
| P373 | Commons category | String | Carbamazepine | ??? |
| P1889 | different from | ... | Q409267 (diethylcarbamazine) | diethylcarbamazine |
| P1542 | has effect | ... | Q55009047 (carbamazepine allergy) | carbamazepine allergy |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P1987 | MCN code | String | 2933.99.32 | ??? |
| P2175 | medical condition treated | ... | Q41112 (schizophrenia) | schizophrenia |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q202387 (post-traumatic stress disorder) | post-traumatic stress disorder |
| P2175 | medical condition treated | ... | Q188638 (mood disorder) | mood disorder |
| P2175 | medical condition treated | ... | Q616667 (temporal lobe epilepsy) | temporal lobe epilepsy |
| P2175 | medical condition treated | ... | Q1132120 (trigeminal neuralgia) | trigeminal neuralgia |
| P2175 | medical condition treated | ... | Q1406803 (tonic–clonic seizure) | tonic–clonic seizure |
| P2175 | medical condition treated | ... | Q2895302 (complex partial seizure) | complex partial seizure |
| P2175 | medical condition treated | ... | Q916280 (restless legs syndrome) | restless legs syndrome |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408977 (vincristine) | vincristine |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q411478 (fluconazole) | fluconazole |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q241006 (desmopressin) | desmopressin |
| P769 | significant drug interaction | ... | Q423169 (isoniazid) | isoniazid |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q422442 (doxycycline) | doxycycline |
| P769 | significant drug interaction | ... | Q418656 (procarbazine) | procarbazine |
| P769 | significant drug interaction | ... | Q419652 (danazol) | danazol |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q4875166 (bazedoxifene) | bazedoxifene |
| P769 | significant drug interaction | ... | Q5138908 (cobicistat) | cobicistat |
| P769 | significant drug interaction | ... | Q773449 (L-thyroxine) | L-thyroxine |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P9989 | stylized name | String | TEGretol | ??? |
| P9989 | stylized name | String | carBAMazepine | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q1747785 (non-opioid analgesic) | non-opioid analgesic |
| P2868 | subject has role | ... | Q11497468 (antimanic agents) | antimanic agents |
| P2868 | subject has role | ... | Q50430523 (cytochrome P-450 CYP3A inducers) | cytochrome P-450 CYP3A inducers |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | carbamazepine | ??? |
Why not click here or view trends?
log id: None